rifabutin (Avera McKennan Hospital)
Welcome to the PulseAid listing for the rifabutin drug offered from Avera McKennan Hospital. This Rifamycin Antimycobacterial [EPC],Rifamycins [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Avera McKennan Hospital |
NON-PROPRIETARY NAME: | rifabutin |
SUBSTANCE NAME: | RIFABUTIN |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Rifamycin Antimycobacterial [EPC],Rifamycins [Chemical/Ingredient] |
ROUTE: | ORAL |
DOSAGE FORM: | CAPSULE |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2016-03-03 |
END MARKETING DATE: | 0000-00-00 |
rifabutin HUMAN PRESCRIPTION DRUG Details:
Item Description | rifabutin from Avera McKennan Hospital |
LABELER NAME: | Avera McKennan Hospital |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 150(mg/1) |
START MARKETING DATE: | 2016-03-03 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 69189-0549_5b9408ef-8531-4893-a053-7f3af2b383d7 |
PRODUCT NDC: | 69189-0549 |
APPLICATION NUMBER: | ANDA090033 |
Other RIFABUTIN Pharmaceutical Manufacturers / Labelers: